Condition 1: Radicular Low Back Pain. Condition 2: DISC HERNIATION. Low back pain Unspecified thoracic, thoracolumbar and lumbosacral intervertebral disc disorder
Conditions
Interventions
Intervention 1: Intervention group: Patients receiving a dose of 40 micrograms per milliliter of ozone or group O3 40mg. Intervention 2: Intervention group: Patients receiving a dose of 20 micrograms
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients with diffuse low back pain with minimal pain intensity 4 according to VAS criteria At least 1 month of low back pain Failure to respond to supportive therapy (such as medication or physiotherapy) Age 30-60 years old Patients with body mass index 20-35 MRI based on the presence of a disc herniation whose location is associated with symptoms
Exclusion criteria
Exclusion criteria: Previous spinal surgery Bone lesions of the spine or spinal cord History of receiving ozone or topical injection of any other drug Pregnancy Spinal cord diseases Uncontrolled diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient with low back pain on minimum scale 4 of VAS. Timepoint: before the study, 3 month and 6 month after the beginning. Method of measurement: VAS questionnaire.;Functional progress in patient with low back pain. Timepoint: before the study, 3 month and 6 month after the beginning. Method of measurement: functional tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzieh Urumieh
Iran University of Medical Sciences
Outcome results
None listed